Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1622, 2008-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin cost effective versus ceftriaxone in AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. :
Moxifloxacin cost effective versus ceftriaxone in AECB
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Ceftriaxone/cefuroxime: First report of serum sickness-like reactions: case report
Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. :
Clinical Use of Cefuroxime in Paediatric Community-Acquired Pneumonia
By Olivier C.
Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. :
Moxifloxacin cost saving for community-acquired pneumonia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 554, 2008-01 ,pp. :